Knee osteoarthritis is one of the most common joint problems in the world, affecting hundreds of millions of people.
As people live longer and rates of obesity continue to rise, this condition is becoming an even bigger health challenge. Knee osteoarthritis often causes ongoing pain, stiffness, swelling, and difficulty walking.
For many older adults, it can lead to loss of independence, poorer quality of life, and even higher risk of early death. Despite how common and serious it is, there is still no cure. Most treatments focus on managing symptoms rather than stopping the disease itself.
In recent years, scientists have paid more attention to inflammation in knee osteoarthritis. While osteoarthritis was once seen as a “wear and tear” condition, research now shows that inflammation plays an important role in many patients. Two tissues inside the knee are especially important in this process.
One is the joint lining, which helps produce fluid for smooth movement. The other is a soft pad of fat located under the kneecap, known as the infrapatellar fat pad. These two tissues are closely connected and can send inflammatory signals that worsen pain and joint damage.
Many people with knee osteoarthritis develop swelling inside the joint. This swelling often comes from a mix of extra fluid and thickening of the joint lining. Doctors call this condition effusion synovitis.
Studies suggest that nearly half of people with knee osteoarthritis have this problem. Effusion synovitis is linked to more pain, faster cartilage loss, damage to the bone under the cartilage, and a higher chance of eventually needing knee replacement surgery.
The infrapatellar fat pad has also drawn attention because it is not just passive fat. When it becomes unhealthy, it can release substances that promote inflammation.
These substances may affect cartilage, the joint lining, and nearby bone. Because of this, scientists have wondered whether treating inflammation directly in the fat pad might reduce pain and protect the knee joint.
Glucocorticoids, often called steroid medications, are already widely used to reduce inflammation and pain in joints. They are commonly injected directly into the knee joint. However, there are concerns that repeated steroid injections may speed up cartilage damage over time.
Injecting glucocorticoids directly into the fat pad under the kneecap was suggested as a possible alternative. The idea was that this approach could calm inflammation at its source while lowering the risk of harming cartilage.
To test this idea, researchers in China carried out a carefully designed clinical trial. The study was published in JAMA Network Open and involved 60 people with inflammatory knee osteoarthritis.
The participants were treated at four medical centers between April 2022 and June 2023. The study lasted 12 weeks, with check-ups at the start and at weeks four, eight, and twelve. MRI scans were done at the beginning and at the end of the study to look closely at changes inside the knee.
Each participant received a single injection into the infrapatellar fat pad. Half were given a glucocorticoid injection, while the other half received a saline injection that acted as a placebo. Neither the participants nor the researchers knew who received which treatment. This helped ensure fair and unbiased results.
Over the 12 weeks, knee pain improved in both groups. Swelling inside the knee also decreased in both groups. Scores that measured daily function and quality of life improved as well.
However, when researchers compared the two groups, they found no meaningful difference between them. In other words, the glucocorticoid injection did not reduce pain or swelling more than the saline injection.
One interesting finding was that cartilage damage scores showed some improvement in the glucocorticoid group compared with the placebo group. However, this result needs to be interpreted carefully. The study was short, and it is not clear whether this small difference would last or lead to real long-term benefits.
Side effects were rare. Only one person in each group reported worse knee pain after the injection. No serious safety problems were reported during the study.
After reviewing all the results, the researchers concluded that injecting glucocorticoids into the infrapatellar fat pad did not provide clear benefits for pain relief or reduction of joint swelling over a 12-week period.
They also noted important limitations. The study followed patients for only three months, which may not be long enough to detect changes in joint structure, fat pad health, or cartilage loss. Larger and longer studies are needed to see whether this approach could offer benefits over time or in specific groups of patients.
Overall, this study provides an important reality check. While targeting inflammation in the knee fat pad sounded promising, the results suggest that it does not offer clear short-term advantages over placebo treatment.
The findings remind us that knee osteoarthritis is a complex disease, and simple solutions may not work as hoped. Future research should continue exploring safer and more effective ways to reduce inflammation, protect cartilage, and improve quality of life for people living with this challenging condition.
If you care about arthritis, please read studies about extra virgin olive oil for arthritis, and pomegranate: A natural treatment for rheumatoid arthritis.
For more information about arthritis, please see recent studies about how to live pain-free with arthritis, and results showing medical cannabis may help reduce arthritis pain, back pain.
The study is published in JAMA Network Open.
Copyright © 2025 Knowridge Science Report. All rights reserved.
